baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC TUR.WAR.OP.END. ICY/ DE000HG98J09 /

2024-05-24 9:36:29 PM	Chg.-0.0400	Bid9:58:35 PM	Ask9:58:35 PM	Underlying	Strike price	Expiration date	Option type
0.7300EUR	-5.19%	0.7000 Bid Size: 30,000	0.7300 Ask Size: 30,000	Incyte Corporation	49.9117 USD	2078-12-31	Call

GlobeNewswire 05-09 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 04-30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 04-02 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 04-01 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 02-28 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 01-09 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 2023-12-12 Wall Street closes higher after inflation report

GlobeNewswire 2023-12-09 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 2023-11-16 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 2023-11-02 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 2023-10-23 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

GlobeNewswire 2023-10-12 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

GlobeNewswire 2023-09-27 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

TeleTrader 2023-09-18 Wall Street opens mostly lower, Fed anticipation builds up

GlobeNewswire 2023-08-28 Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

TeleTrader 2023-02-07 Wall Street back to losses, Dow slides 200 points

TeleTrader 2023-02-07 US markets lower amid economic data, Fed's Powell

GlobeNewswire 2022-03-23 RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...

GlobeNewswire 2022-03-14 STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations

GlobeNewswire 2022-03-01 Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...

GlobeNewswire 2022-02-28 Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...

GlobeNewswire 2022-02-24 MacroGenics Provides Update on Corporate Progress and 2021 Financial Results

GlobeNewswire 2022-01-25 Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145

GlobeNewswire 2022-01-10 Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agre...

HSBC TUR.WAR.OP.END. ICY/ DE000HG98J09 /

If you wish to receive reply to your feedback, please provide your email address.